Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms

Table 6

Assay results for commercial formulation.

Amount present (mg)	(%)	Amount present (mg)	(%)	Amount present (mg)	(%)
EMT		TDF		RPV
198.21	99.10	300.48	100.16	24.92	99.70
199.07	99.53	299.81	99.93	24.91	99.65
198.21	99.10	296.63	98.87	24.63	98.54
201.12	100.56	299.57	99.85	24.92	99.70
200.55	100.27	298.91	99.63	24.94	99.77
199.92	99.96	300.48	100.16	24.91	99.65
S.D	0.579	S.D	0.494	S.D	0.523
%RSD	0.579	%RSD	0.495	%RSD	0.525